Evidence for persistent Chlamydia pneumoniae infection of human coronary atheromas

Atherosclerosis

Volumn 199, Issue 1, 2008, Pages 154-161

  Borel, Nicole ^a   Summersgill, James T ^b   Mukhopadhyay, Sanghamitra ^b   Miller, Richard D ^b   Ramirez, Julio A ^b   Pospischil, Andreas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b University of Louisville School of Medicine   (United States)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Immunogold electron microscopy; Persistent infection

Indexed keywords

BACTERIUM ANTIBODY;

ARTICLE; ATHEROMA; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOGOLD ELECTRON MICROSCOPY; IN VIVO STUDY; PERSISTENT INFECTION; PRIORITY JOURNAL;

ANTIBODIES, BACTERIAL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CORONARY ARTERY DISEASE; CORONARY VESSELS; GROEL PROTEIN; GROES PROTEIN; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 45249114643     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.09.026     Document Type: Article

References (13)

1. Kalayoglu M.V., Libby P., and Byrne G.I. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 288 (2002) 2724-2731
2. Ramirez J.A. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 125 (1996) 979-982
3. Hogan R.J., Mathews S.A., Mukhopadhyay S., Summersgill J.T., and Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 72 (2004) 1843-1855
4. Summersgill J.T., Sahney N.N., Gaydos C.A., Quinn T.C., and Ramirez J.A. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun 36 (1995) 2801-2803
5. Mehta S.J., Miller R.D., Ramirez J.A., and Summersgill J.T. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-γ: role of tryptophan catabolism. J Infect Dis 177 (1998) 1326-1331
6. Pantoja L.G., Miller R.D., Ramirez J.A., Molestina R.E., and Summersgill J.T. Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect Immun 69 (2001) 7927-7932
7. Molestina R.E., Klein J.B., Miller R.D., Pierce W.H., Ramirez J.A., and Summersgill J.T. Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun 70 (2002) 2976-2981
8. Mukhopadhyay S., Miller R.D., Sullivan E.D., et al. Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun 74 (2006) 3853-3863
9. Borel N., Mukhopadhyay S., Kaiser C., et al. Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infection. BMC Infect Dis 19 6 (2006) 152
10. Merighi A. Post-embedding electron microscopic immunocytochemistry. In: Polak J.M., and Priestley J.V. (Eds). Electron microscopic immunocytochemistry: principles and practice (1992), University Press, New York 51-87
11. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
12. Gieffers J., Fullgraf H., Jahn J., et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 103 (2001) 351-356
13. Andraws R., Berger J.S., and Brown D.L. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 293 (2005) 2641-2647